1. Volume 70, Issue 1, Pages 170-176 (July 2006)
Effect of spironolactone and captopril on nitric oxide and S-nitrosothiol formation in kidney of L-NAME-treated rats 
O. Pechanova, J. Matuskova, D. Capikova, L. Jendekova, L. Paulis, F. Simko 
Kidney International 
Volume 70, Issue 1, Pages (July 2006)
DOI: /sj.ki
Copyright © 2006 International Society of Nephrology Terms and Conditions

2. Figure 1
Effect of 4-week L-NAME, spironolactone, L-NAME+spironolactone, captopril, and L-NAME+captopril treatment on SBP. Ctrl – control, LN – 40 mg/kg/day L-NAME, S – spironolactone 200 mg/kg/day, SL – L-NAME+spironolactone in corresponding doses, C – captopril 100 mg/kg/day, CL – L-NAME+captopril in corresponding doses. Significant differences: *P<0.05 compared to controls, +P<0.05 compared to L-NAME group.
Kidney International  , DOI: ( /sj.ki )
Copyright © 2006 International Society of Nephrology Terms and Conditions

3. Figure 2
Effect of 4-week L-NAME, spironolactone, L-NAME+spironolactone, captopril, and L-NAME+captopril treatment on NOS activity in the kidney. Ctrl – control, LN – 40 mg/kg/day L-NAME, S – spironolactone 200 mg/kg/day, LS – L-NAME+spironolactone in corresponding doses, C – captopril 100 mg/kg/day, LC – L-NAME+captopril in corresponding doses. *P<0.05 compared to control, +P<0.05 compared to L-NAME group.
Kidney International  , DOI: ( /sj.ki )
Copyright © 2006 International Society of Nephrology Terms and Conditions

4. Figure 3
Effect of 4-week L-NAME+ spironolactone, L-NAME+spironolactone, captopril, and L-NAME+captopril treatment on eNOS and β-actin expression in the kidney. Ctrl – control, LN – 40 mg/kg/day L-NAME, S – spironolactone 200 mg/kg/day, LS – L-NAME+spironolactone in corresponding doses, C – captopril 100 mg/kg/day, LC – L-NAME+captopril in corresponding doses. *P<0.05 compared to control, +P<0.05 compared to L-NAME group.
Kidney International  , DOI: ( /sj.ki )
Copyright © 2006 International Society of Nephrology Terms and Conditions

5. Figure 4
Effect of 4-week L-NAME, spironolactone, L-NAME+spironolactone, captopril, and L-NAME+captopril treatment on iNOS and β-actin expression in the kidney. Ctrl – control, LN – 40 mg/kg/day L-NAME, S – spironolactone 200 mg/kg/day, LS – L-NAME+spironolactone in corresponding doses, C – captopril 100 mg/kg/day, LC – L-NAME+captopril in corresponding doses.
Kidney International  , DOI: ( /sj.ki )
Copyright © 2006 International Society of Nephrology Terms and Conditions

6. Figure 5
Effect of 4-week L-NAME, spironolactone, L-NAME+spironolactone, captopril, and L-NAME+captopril treatment on thiol group concentration in the kidney. Ctrl – control, LN – 40 mg/kg/day L-NAME, S – spironolactone 200 mg/kg/day, LS – L-NAME+spironolactone in corresponding doses, C – captopril 100 mg/kg/day, LC – L-NAME+captopril in corresponding doses. *P<0.05 compared to control, +P<0.05 compared to L-NAME group.
Kidney International  , DOI: ( /sj.ki )
Copyright © 2006 International Society of Nephrology Terms and Conditions

7. Figure 6
Effect of 4-week L-NAME, spironolactone, L-NAME+spironolactone, captopril, and L-NAME+captopril treatment on S-nitrosothiol group concentration in the kidney. Ctrl – control, LN – 40 mg/kg/day L-NAME, S – spironolactone 200 mg/kg/day, LS – L-NAME+spironolactone in corresponding doses, C – captopril 100 mg/kg/day, LC – L-NAME+captopril in corresponding doses. *P<0.05 compared to control, +P<0.05 compared to L-NAME group.
Kidney International  , DOI: ( /sj.ki )
Copyright © 2006 International Society of Nephrology Terms and Conditions